Pub Date : 2024-01-06DOI: 10.1016/j.mayocpiqo.2023.12.007
Edvard H. Sagelv PhD , Andrea Casolo PhD , Anne Elise Eggen PhD , Kim Arne Heitmann PhD , Kristoffer R. Johansen MSc , Maja-Lisa Løchen PhD , Ellisiv B. Mathiesen PhD , Bente Morseth PhD , Inger Njølstad PhD , John O. Osborne PhD , Karianne Hagerupsen MSc , Sigurd Pedersen PhD , Tom Wilsgaard PhD
Objective
To examine the dose-response association between estimated cardiorespiratory fitness (eCRF) and risk of myocardial infarction (MI).
Patients and Methods
Adults who attended Tromsø Study surveys 4-6 (Janurary 1,1994-December 20, 2008) with no previous cardiovascular disease were followed up through December 31, 2014 for incident MI. Associations were examined using restricted cubic splines Fine and Gray regressions, adjusted for education, smoking, alcohol, diet, sex, adiposity, physical activity, study survey, and age (timescale) in the total cohort and subsamples with hyperlipidemia (n=2956), hypertension (n=8290), obesity (n=5784), metabolic syndrome (n=1410), smokers (n=3823), and poor diet (n=3463) and in those who were physically inactive (n=6255).
Results
Of 14,285 participants (mean age ± SD, 53.7±11.4 years), 979 (6.9%) experienced MI during follow-up (median, 7.2 years; 25th-75th, 5.3-14.6 years). Females with median eCRF (32 mL/kg/min) had 43% lower MI risk (subdistributed hazard ratio [SHR], 0.57; 95% CI, 0.48-0.68) than those at the 10th percentile (25 mL/kg/min) as reference. The lowest MI risk was observed at 47 mL/kg/min (SHR, 0.02; 95% CI, 0.01-0.11). Males had 26% lower MI risk at median eCRF (40 mL/kg/min; SHR, 0.74; 95% CI, 0.63-0.86) than those at the 10th percentile (32 mL/kg/min), and the lowest risk was 69% (SHR, 0.31; 95% CI, 0.14-0.71) at 60 mL/kg/min. The associations were similar in subsamples with cardiovascular disease risk factors.
Conclusion
Higher eCRF associated with lower MI risk in females and males, but associations were more pronounced among females than those in males. This suggest eCRF as a vital estimate to implement in medical care to identify individuals at high risk of future MI, especially for females.
{"title":"Females Display Lower Risk of Myocardial Infarction From Higher Estimated Cardiorespiratory Fitness Than Males: The Tromsø Study 1994-2014","authors":"Edvard H. Sagelv PhD , Andrea Casolo PhD , Anne Elise Eggen PhD , Kim Arne Heitmann PhD , Kristoffer R. Johansen MSc , Maja-Lisa Løchen PhD , Ellisiv B. Mathiesen PhD , Bente Morseth PhD , Inger Njølstad PhD , John O. Osborne PhD , Karianne Hagerupsen MSc , Sigurd Pedersen PhD , Tom Wilsgaard PhD","doi":"10.1016/j.mayocpiqo.2023.12.007","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.12.007","url":null,"abstract":"<div><h3>Objective</h3><p>To examine the dose-response association between estimated cardiorespiratory fitness (eCRF) and risk of myocardial infarction (MI).</p></div><div><h3>Patients and Methods</h3><p>Adults who attended Tromsø Study surveys 4-6 (Janurary 1,1994-December 20, 2008) with no previous cardiovascular disease were followed up through December 31, 2014 for incident MI. Associations were examined using restricted cubic splines Fine and Gray regressions, adjusted for education, smoking, alcohol, diet, sex, adiposity, physical activity, study survey, and age (timescale) in the total cohort and subsamples with hyperlipidemia (n=2956), hypertension (n=8290), obesity (n=5784), metabolic syndrome (n=1410), smokers (n=3823), and poor diet (n=3463) and in those who were physically inactive (n=6255).</p></div><div><h3>Results</h3><p>Of 14,285 participants (mean age ± SD, 53.7±11.4 years), 979 (6.9%) experienced MI during follow-up (median, 7.2 years; 25th-75th, 5.3-14.6 years). Females with median eCRF (32 mL/kg/min) had 43% lower MI risk (subdistributed hazard ratio [SHR], 0.57; 95% CI, 0.48-0.68) than those at the 10th percentile (25 mL/kg/min) as reference. The lowest MI risk was observed at 47 mL/kg/min (SHR, 0.02; 95% CI, 0.01-0.11). Males had 26% lower MI risk at median eCRF (40 mL/kg/min; SHR, 0.74; 95% CI, 0.63-0.86) than those at the 10th percentile (32 mL/kg/min), and the lowest risk was 69% (SHR, 0.31; 95% CI, 0.14-0.71) at 60 mL/kg/min. The associations were similar in subsamples with cardiovascular disease risk factors.</p></div><div><h3>Conclusion</h3><p>Higher eCRF associated with lower MI risk in females and males, but associations were more pronounced among females than those in males. This suggest eCRF as a vital estimate to implement in medical care to identify individuals at high risk of future MI, especially for females.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 62-73"},"PeriodicalIF":0.0,"publicationDate":"2024-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000826/pdfft?md5=faf6ca2d58c1b47ae0380a6e7c317a24&pid=1-s2.0-S2542454823000826-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139111519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-05DOI: 10.1016/j.mayocpiqo.2023.12.006
Benjamin A. Satterfield MD, PhD , Ozan Dikilitas MD , Holly Van Houten BA , Xiaoxi Yao PhD, MPH , Bernard J. Gersh MBChB, DPhil
We investigated the association of daylight saving time (DST) transitions with the rates of adverse cardiovascular events in a large, US-based nationwide study. The study cohort included 36,116,951 unique individuals from deidentified administrative claims data of the OptumLabs Data Warehouse. There were 74,722 total adverse cardiovascular events during DST transition and the control weeks (2 weeks before and after) in spring and autumn of 2015-2019. We used Bayesian hierarchical Poisson regression models to estimate event rate ratios representing the ratio of composite adverse cardiovascular event rates between DST transition and control weeks. There was an average increase of 3% (95% uncertainty interval, −3% to −10%) and 4% (95% uncertainty interval, −2% to −12%) in adverse cardiovascular event rates during Monday and Friday of the spring DST transition, respectively. The probability of this being associated with a moderate-to-large increase in the event rates (estimate event rate ratio, >1.10) was estimated to be less than 6% for Monday and Friday, and less than 1% for the remaining days. During autumn DST transition, the probability of any decrease in adverse cardiovascular event rates was estimated to be less than 46% and a moderate-to-large decrease in the event rates to be less than 4% across all days. Results were similar when adjusted by age. In conclusion, spring DST transition had a suggestive association with a minor increase in adverse cardiovascular event rates but with a very low estimated probability to be of clinical importance. Our findings suggest that DST transitions are unlikely to meaningfully impact the rate of cardiovascular events.
{"title":"Daylight Saving Time Practice and the Rate of Adverse Cardiovascular Events in the United States: A Probabilistic Assessment in a Large Nationwide Study","authors":"Benjamin A. Satterfield MD, PhD , Ozan Dikilitas MD , Holly Van Houten BA , Xiaoxi Yao PhD, MPH , Bernard J. Gersh MBChB, DPhil","doi":"10.1016/j.mayocpiqo.2023.12.006","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.12.006","url":null,"abstract":"<div><p>We investigated the association of daylight saving time (DST) transitions with the rates of adverse cardiovascular events in a large, US-based nationwide study. The study cohort included 36,116,951 unique individuals from deidentified administrative claims data of the OptumLabs Data Warehouse. There were 74,722 total adverse cardiovascular events during DST transition and the control weeks (2 weeks before and after) in spring and autumn of 2015-2019. We used Bayesian hierarchical Poisson regression models to estimate event rate ratios representing the ratio of composite adverse cardiovascular event rates between DST transition and control weeks. There was an average increase of 3% (95% uncertainty interval, −3% to −10%) and 4% (95% uncertainty interval, −2% to −12%) in adverse cardiovascular event rates during Monday and Friday of the spring DST transition, respectively. The probability of this being associated with a moderate-to-large increase in the event rates (estimate event rate ratio, >1.10) was estimated to be less than 6% for Monday and Friday, and less than 1% for the remaining days. During autumn DST transition, the probability of any decrease in adverse cardiovascular event rates was estimated to be less than 46% and a moderate-to-large decrease in the event rates to be less than 4% across all days. Results were similar when adjusted by age. In conclusion, spring DST transition had a suggestive association with a minor increase in adverse cardiovascular event rates but with a very low estimated probability to be of clinical importance. Our findings suggest that DST transitions are unlikely to meaningfully impact the rate of cardiovascular events.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 45-52"},"PeriodicalIF":0.0,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000814/pdfft?md5=8383a94342c93556eb14bd0bb98b66ae&pid=1-s2.0-S2542454823000814-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139107410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-04DOI: 10.1016/j.mayocpiqo.2023.12.003
Ishaan Gupta MBBS, Ilana Nelson-Greenberg MD, Scott Mitchell Wright MD, Ché Matthew Harris MD, MS
Objective
To determine the change in rates of physical restraint (PR) use and associated outcomes among hospitalized adults.
Patients and Methods
Using national inpatient sample databases, we analyzed years 2011-2014 and 2016-2019 to determine trends of PR usage. We also compared the years 2011-2012 and 2018-2019 to investigate rates of PR use, in-hospital mortality, length of stay, and total hospital charges.
Results
There were 242,994,110 hospitalizations during the study period. 1,538,791 (0.63%) had coding to signify PRs, compared with 241,455,319 (99.3%), which did not. From 2011 to 2014, there was a significant increase in PR use (p-trend<.01) and a nonsignificant increase in PR rates from 2016-2019 (p-trend=.07). Over time, PR use increased (2011-2012: 0.52% vs 2018-2019: 0.73%; p<.01). Patients with PRs reported a higher adjusted odds for in-hospital mortality in 2011-2012 (adjusted odds ratio [aOR], 3.9; 95% CI, 3.7-4.2; p<.01) and 2018-2019 (aOR, 3.5; 95% CI, 3.4-3.7; p<.01). Length of stay was prolonged for patients with PRs in 2011-2012 (adjusted mean difference [aMD], 4.3 days; 95% CI, 4.1-4.5; p<.01) and even longer in 2018-2019 (aMD, 5.8 days; 95% CI, 5.6-6.0; p<.01). Total hospital charges were higher for patients with PRs in 2011-2012 (aMD, +$55,003; 95% CI, $49,309-$60,679; p<.01). Following adjustment for inflation, total charges remained higher for patients with PRs compared with those without PRs in 2018-2019 (aMD, +$70,018; 95% CI, $65,355-$74,680; p<.01).
Conclusion
Overall, PR rates did not decrease across the study period, suggesting that messaging and promulgating best practice guidelines have yet to translate into a substantive change in practice patterns.
{"title":"Physical Restraint Usage in Hospitals Across the United States: 2011-2019","authors":"Ishaan Gupta MBBS, Ilana Nelson-Greenberg MD, Scott Mitchell Wright MD, Ché Matthew Harris MD, MS","doi":"10.1016/j.mayocpiqo.2023.12.003","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.12.003","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the change in rates of physical restraint (PR) use and associated outcomes among hospitalized adults.</p></div><div><h3>Patients and Methods</h3><p>Using national inpatient sample databases, we analyzed years 2011-2014 and 2016-2019 to determine trends of PR usage. We also compared the years 2011-2012 and 2018-2019 to investigate rates of PR use, in-hospital mortality, length of stay, and total hospital charges.</p></div><div><h3>Results</h3><p>There were 242,994,110 hospitalizations during the study period. 1,538,791 (0.63%) had coding to signify PRs, compared with 241,455,319 (99.3%), which did not. From 2011 to 2014, there was a significant increase in PR use (<em>p-</em>trend<.01) and a nonsignificant increase in PR rates from 2016-2019 (<em>p-</em>trend=.07). Over time, PR use increased (2011-2012: 0.52% vs 2018-2019: 0.73%; <em>p</em><.01). Patients with PRs reported a higher adjusted odds for in-hospital mortality in 2011-2012 (adjusted odds ratio [aOR], 3.9; 95% CI, 3.7-4.2; <em>p</em><.01) and 2018-2019 (aOR, 3.5; 95% CI, 3.4-3.7; <em>p</em><.01). Length of stay was prolonged for patients with PRs in 2011-2012 (adjusted mean difference [aMD], 4.3 days; 95% CI, 4.1-4.5; <em>p</em><.01) and even longer in 2018-2019 (aMD, 5.8 days; 95% CI, 5.6-6.0; <em>p</em><.01). Total hospital charges were higher for patients with PRs in 2011-2012 (aMD, +$55,003; 95% CI, $49,309-$60,679; <em>p</em><.01). Following adjustment for inflation, total charges remained higher for patients with PRs compared with those without PRs in 2018-2019 (aMD, +$70,018; 95% CI, $65,355-$74,680; <em>p</em><.01).</p></div><div><h3>Conclusion</h3><p>Overall, PR rates did not decrease across the study period, suggesting that messaging and promulgating best practice guidelines have yet to translate into a substantive change in practice patterns.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 37-44"},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000784/pdfft?md5=251e31df642d392cd42bba037377ce0e&pid=1-s2.0-S2542454823000784-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139107407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-26DOI: 10.1016/j.mayocpiqo.2023.11.002
Kaitlin Roehl PA-C , Carolyn Mead-Harvey MS , Heidi M. Connolly MD , Joseph A. Dearani MD , Felicia S. Schaap APRN, AGACNP-BC , Susanna L. Liljenstolpe APRN, FNP-C , Linda B. Osborn RN , C. Charles Jain MD , Donald J. Hagler Sr. MD , Francois Marcotte MD , David S. Majdalany MD
Objective
To assess risks and benefits of cardiac intervention in adults with Down syndrome (DS).
Patients and Methods
A retrospective review was conducted using data from a study we published in 2010. Patients aged 18 years or older with DS who underwent cardiac operation or percutaneous intervention from February 2009 through April 2022 (new cohort) were compared with patients in the previous study (January 1969 through November 2007; remote cohort) at Mayo Clinic.
Results
In total, 81 adults (43 men; 38 women) with DS underwent 89 cardiac interventions (84 surgical; 5 percutaneous) at a mean age of 33 years. Twenty-six patients presented with complete atrioventricular canal defect (17%) or tetralogy of Fallot (15%). The most common adult procedures were valve interventions: mitral (31%), tricuspid (15%), and pulmonary (12%). Of pulmonary valve interventions in the new cohort, 33% were performed percutaneously. The postoperative mortality rate was low (1% total). The mean time between last operation and death was 16 years.
Conclusion
Adults with DS can undergo cardiac operation and percutaneous intervention with low morbidity and mortality risk and good long-term survival.
{"title":"Safety and Efficacy of Surgical and Percutaneous Cardiac Interventions for Adults With Down Syndrome","authors":"Kaitlin Roehl PA-C , Carolyn Mead-Harvey MS , Heidi M. Connolly MD , Joseph A. Dearani MD , Felicia S. Schaap APRN, AGACNP-BC , Susanna L. Liljenstolpe APRN, FNP-C , Linda B. Osborn RN , C. Charles Jain MD , Donald J. Hagler Sr. MD , Francois Marcotte MD , David S. Majdalany MD","doi":"10.1016/j.mayocpiqo.2023.11.002","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.11.002","url":null,"abstract":"<div><h3>Objective</h3><p>To assess risks and benefits of cardiac intervention in adults with Down syndrome (DS).</p></div><div><h3>Patients and Methods</h3><p>A retrospective review was conducted using data from a study we published in 2010. Patients aged 18 years or older with DS who underwent cardiac operation or percutaneous intervention from February 2009 through April 2022 (new cohort) were compared with patients in the previous study (January 1969 through November 2007; remote cohort) at Mayo Clinic.</p></div><div><h3>Results</h3><p>In total, 81 adults (43 men; 38 women) with DS underwent 89 cardiac interventions (84 surgical; 5 percutaneous) at a mean age of 33 years. Twenty-six patients presented with complete atrioventricular canal defect (17%) or tetralogy of Fallot (15%). The most common adult procedures were valve interventions: mitral (31%), tricuspid (15%), and pulmonary (12%). Of pulmonary valve interventions in the new cohort, 33% were performed percutaneously. The postoperative mortality rate was low (1% total). The mean time between last operation and death was 16 years.</p></div><div><h3>Conclusion</h3><p>Adults with DS can undergo cardiac operation and percutaneous intervention with low morbidity and mortality risk and good long-term survival.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 28-36"},"PeriodicalIF":0.0,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000735/pdfft?md5=adb10ed4913539d603291b2c058c3d1c&pid=1-s2.0-S2542454823000735-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139050152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-25DOI: 10.1016/j.mayocpiqo.2023.11.003
Nathan A. Seven MD , Karen A. Truitt DO , Ross A. Dierkhising MS , Nathan P. Young DO
Objective
To describe our practice of electronic consultations (e-consults) and assess safety and risk factors for subsequent face-to-face consultations.
Patients and Methods
A retrospective cohort study of all e-consults completed in a community neurology practice between May 5, 2018, and June 31, 2019, was completed. Clinical and demographic variables were compared between the successful and unsuccessful (defined by presence of subsequent face-to-face consultation) cohorts. Hazard ratios (HR) were calculated using Cox regression model. Kaplan-Meier probability analysis (with 95% CIs) of subsequent face-to-face consultation was performed. Case examples highlighting potential harm were summarized.
Results
In total, 302 e-consults were reviewed. The most frequent referrals were for headache (n=125, 41.4%), dysesthesia (n=40, 13.2%), and abnormal imaging finding (n=27, 8.9%). The most common e-consult questions were for treatment (57.6%) and diagnostic evaluation (48.0%) recommendations. Moreover, 24.8% (n=75) of e-consults were followed by face-to-face consultations, with primary risk factors including female sex (HR, 1.9), referral for headache (HR, 1.7), and final diagnosis of migraine (HR, 2.0) or long-term migraine (HR, 5.0). Potential harm related to delayed diagnosis/treatment was identified in 6 (2.0%) patients with migraine and 4 (1.3%) without migraine presenting to emergency department.
Conclusion
Utilization of e-consults may safely improve access to neurologic expertise and prevent the need for some visits, which may have required a face-to-face visit. In patients with chronic migraine, e-consults should be considered short-term and followed by face-to-face consultation as soon as access allows. Neurologists performing e-consults should be able to triage patients to face-to-face consultation, particularly when diagnosis is uncertain or the neurologic examination may help guide appropriate testing.
{"title":"Electronic Consultations in a Community Neurology Practice: A Retrospective Study Informing Best Practice","authors":"Nathan A. Seven MD , Karen A. Truitt DO , Ross A. Dierkhising MS , Nathan P. Young DO","doi":"10.1016/j.mayocpiqo.2023.11.003","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.11.003","url":null,"abstract":"<div><h3>Objective</h3><p>To describe our practice of electronic consultations (e-consults) and assess safety and risk factors for subsequent face-to-face consultations.</p></div><div><h3>Patients and Methods</h3><p>A retrospective cohort study of all e-consults completed in a community neurology practice between May 5, 2018, and June 31, 2019, was completed. Clinical and demographic variables were compared between the successful and unsuccessful (defined by presence of subsequent face-to-face consultation) cohorts. Hazard ratios (HR) were calculated using Cox regression model. Kaplan-Meier probability analysis (with 95% CIs) of subsequent face-to-face consultation was performed. Case examples highlighting potential harm were summarized.</p></div><div><h3>Results</h3><p>In total, 302 e-consults were reviewed. The most frequent referrals were for headache (n=125, 41.4%), dysesthesia (n=40, 13.2%), and abnormal imaging finding (n=27, 8.9%). The most common e-consult questions were for treatment (57.6%) and diagnostic evaluation (48.0%) recommendations. Moreover, 24.8% (n=75) of e-consults were followed by face-to-face consultations, with primary risk factors including female sex (HR, 1.9), referral for headache (HR, 1.7), and final diagnosis of migraine (HR, 2.0) or long-term migraine (HR, 5.0). Potential harm related to delayed diagnosis/treatment was identified in 6 (2.0%) patients with migraine and 4 (1.3%) without migraine presenting to emergency department.</p></div><div><h3>Conclusion</h3><p>Utilization of e-consults may safely improve access to neurologic expertise and prevent the need for some visits, which may have required a face-to-face visit. In patients with chronic migraine, e-consults should be considered short-term and followed by face-to-face consultation as soon as access allows. Neurologists performing e-consults should be able to triage patients to face-to-face consultation, particularly when diagnosis is uncertain or the neurologic examination may help guide appropriate testing.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 17-27"},"PeriodicalIF":0.0,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000747/pdfft?md5=34d543c79ed67e1a33863ede1816bd8e&pid=1-s2.0-S2542454823000747-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139038572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-12-14DOI: 10.1016/j.mayocpiqo.2023.09.006
Elvira Mukhametova MD , Alena Militskova MS , Artur Biktimirov MD , Nikita Kharin MS , Elena Semenova MS , Oskar Sachenkov PhD , Tatiana Baltina PhD , Igor Lavrov MD, PhD
Objective
To evaluate the effect of transcutaneous (tSCS) and epidural electrical spinal cord stimulation (EES) in facilitating volitional movements, balance, and nonmotor functions, in this observational study, tSCS and EES were consecutively tested in 2 participants with motor complete spinal cord injury (SCI).
Participants and Methods
Two participants (a 48-year-old woman and a 28-year-old man), both classified as motor complete spinal injury, were enrolled in the study. Both participants went through a unified protocol, such as an initial electrophysiological assessment of neural connectivity, consecutive tSCS and EES combined with 8 wks of motor training with electromyography (EMG) and kinematic evaluation. The study was conducted from May 1, 2019, to December 31, 2021.
Results
In both participants, tSCS reported a minimal improvement in voluntary movements still essential to start tSCS-enabled rehabilitation. Compared with tSCS, following EES showed immediate improvement in voluntary movements, whereas tSCS was more effective in improving balance and posture. Continuous improvement in nonmotor functions was found during tSCS-enabled and then during EES-enabled motor training.
Conclusion
Results report a significant difference in the effect of tSCS and EES on the recovery of neurologic functions and support consecutive tSCS and EES applications as a potential therapy for SCI. The proposed approach may help in selecting patients with SCI responsive to neuromodulation. It would also help initiate neuromodulation and rehabilitation therapy early, particularly for motor complete SCI with minimal effect from conventional rehabilitation.
{"title":"Consecutive Transcutaneous and Epidural Spinal Cord Neuromodulation to Modify Clinical Complete Paralysis—the Proof of Concept","authors":"Elvira Mukhametova MD , Alena Militskova MS , Artur Biktimirov MD , Nikita Kharin MS , Elena Semenova MS , Oskar Sachenkov PhD , Tatiana Baltina PhD , Igor Lavrov MD, PhD","doi":"10.1016/j.mayocpiqo.2023.09.006","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.09.006","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the effect of transcutaneous (tSCS) and epidural electrical spinal cord stimulation (EES) in facilitating volitional movements, balance, and nonmotor functions, in this observational study, tSCS and EES were consecutively tested in 2 participants with motor complete spinal cord injury (SCI).</p></div><div><h3>Participants and Methods</h3><p>Two participants (a 48-year-old woman and a 28-year-old man), both classified as motor complete spinal injury, were enrolled in the study. Both participants went through a unified protocol, such as an initial electrophysiological assessment of neural connectivity, consecutive tSCS and EES combined with 8 wks of motor training with electromyography (EMG) and kinematic evaluation. The study was conducted from May 1, 2019, to December 31, 2021.</p></div><div><h3>Results</h3><p>In both participants, tSCS reported a minimal improvement in voluntary movements still essential to start tSCS-enabled rehabilitation. Compared with tSCS, following EES showed immediate improvement in voluntary movements, whereas tSCS was more effective in improving balance and posture. Continuous improvement in nonmotor functions was found during tSCS-enabled and then during EES-enabled motor training.</p></div><div><h3>Conclusion</h3><p>Results report a significant difference in the effect of tSCS and EES on the recovery of neurologic functions and support consecutive tSCS and EES applications as a potential therapy for SCI. The proposed approach may help in selecting patients with SCI responsive to neuromodulation. It would also help initiate neuromodulation and rehabilitation therapy early, particularly for motor complete SCI with minimal effect from conventional rehabilitation.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"8 1","pages":"Pages 1-16"},"PeriodicalIF":0.0,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000644/pdfft?md5=c15d5171a92a6d907c575eb820ff6c71&pid=1-s2.0-S2542454823000644-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138633570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-24DOI: 10.1016/j.mayocpiqo.2023.10.001
Sarah B. Nahhal MD , Johnny Zakhour MD , Abdel Hadi Shmoury MD , Tedy Sawma MD , Sara F. Haddad MD , Tamara Abdallah MSc , Nada Kara Zahreddine CIC , Joseph Tannous MHRM , Nisrine Haddad Pharm D , Nesrine Rizk MD , Souha S. Kanj MD
Objective
To report the microbiological profile of the pathogens implicated in blood stream infections (BSI) in hospitalized coronavirus disease 2019 (COVID-19) patients and to examine the risk factors associated with multidrug-resistant organisms (MDROs) causing BSI.
Patients and Methods
Between March 2020 and September 2021, 1647 patients were hospitalized with COVID-19 at the American University of Beirut. From 85 patients, 299 positive blood cultures were reported to the Infection Control and Prevention Program. The BSI was defined as 1 positive blood culture for bacterial or fungal pathogens. The following organisms were considered MDROs: methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp, carbapenem-resistant Enterobacterales spp., carbapenem-resistant Pseudomonas aeruginosa, MDR Acinetobacter baumannii only susceptible to colistin or tigecycline, and Candida auris.
Results
We identified 99 true positive BSI events. Gram-negative bacteria accounted for 38.4 %, followed by Gram-positive bacteria (37.4%), and fungi (24.2%). The most isolated species were Candida spp. (23%), 3 of which were C. auris, followed by Enterobacterales spp. (13%), Enterococcus spp. (12%), S. aureus (9%), P. aeruginosa (9%), and A. baumannii (3%). The MDROs represented 26% of the events. The overall mortality rate was 78%. The time to acquisition of BSI in patients with MDROs was significantly longer compared with that of non-MDROs (20.2 days vs 11.2 days). And there was a significantly shorter time from acquisition of BSI to mortality between MDROs and non-MDROs (1.5 vs 8.3 days).
Conclusion
Rigorous infection prevention and control measures and antimicrobial stewardship are important to prevent antimicrobial resistance progression, especially in low-resource settings.
{"title":"Blood Stream Infections in COVID-19 Patients From a Tertiary Care Center in Lebanon: Causative Pathogens and Rates of Multi-Drug Resistant Organisms","authors":"Sarah B. Nahhal MD , Johnny Zakhour MD , Abdel Hadi Shmoury MD , Tedy Sawma MD , Sara F. Haddad MD , Tamara Abdallah MSc , Nada Kara Zahreddine CIC , Joseph Tannous MHRM , Nisrine Haddad Pharm D , Nesrine Rizk MD , Souha S. Kanj MD","doi":"10.1016/j.mayocpiqo.2023.10.001","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.10.001","url":null,"abstract":"<div><h3>Objective</h3><p>To report the microbiological profile of the pathogens implicated in blood stream infections (BSI) in hospitalized coronavirus disease 2019 (COVID-19) patients and to examine the risk factors associated with multidrug-resistant organisms (MDROs) causing BSI.</p></div><div><h3>Patients and Methods</h3><p>Between March 2020 and September 2021, 1647 patients were hospitalized with COVID-19 at the American University of Beirut. From 85 patients, 299 positive blood cultures were reported to the Infection Control and Prevention Program. The BSI was defined as 1 positive blood culture for bacterial or fungal pathogens. The following organisms were considered MDROs: methicillin-resistant <em>Staphylococcus aureus</em>, vancomycin-resistant <em>Enterococcus</em> spp, carbapenem-resistant <em>Enterobacterales</em> spp., carbapenem-resistant <em>Pseudomonas aeruginosa</em>, MDR <em>Acinetobacter baumannii</em> only susceptible to colistin or tigecycline, and <em>Candida auris.</em></p></div><div><h3>Results</h3><p>We identified 99 true positive BSI events. Gram-negative bacteria accounted for 38.4 %, followed by Gram-positive bacteria (37.4%), and fungi (24.2%). The most isolated species were <em>Candida</em> spp. (23%), 3 of which were <em>C. auris</em>, followed by <em>Enterobacterales</em> spp. (13%), <em>Enterococcus</em> spp. (12%), <em>S. aureus</em> (9%), <em>P. aeruginosa</em> (9%), and <em>A. baumannii</em> (3%). The MDROs represented 26% of the events. The overall mortality rate was 78%. The time to acquisition of BSI in patients with MDROs was significantly longer compared with that of non-MDROs (20.2 days vs 11.2 days). And there was a significantly shorter time from acquisition of BSI to mortality between MDROs and non-MDROs (1.5 vs 8.3 days).</p></div><div><h3>Conclusion</h3><p>Rigorous infection prevention and control measures and antimicrobial stewardship are important to prevent antimicrobial resistance progression, especially in low-resource settings.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"7 6","pages":"Pages 556-568"},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000681/pdfft?md5=b0a82eabdc062d57635e0b37f75841c8&pid=1-s2.0-S2542454823000681-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138413007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-11-23DOI: 10.1016/j.mayocpiqo.2023.09.005
Debra A. Gilin PhD , Gregory G. Anderson MSc , Seyedehsan Etezad MSc , Dayna Lee-Baggley PhD , Angela M. Cooper PhD, RPsych , Roberta J. Preston EdD
Objective
To evaluate the efficacy of a wellness leadership intervention for improving the empathy, burnout, and physiological stress of medical faculty leaders.
Participants and Methods
Participants were 49 medical faculty leaders (80% physicians, 20% basic scientists; 67% female). The 6-week course was evaluated with a 15-week longitudinal waitlist-control quasi-experiment from September 1, 2021, through December 20, 2021 (during the COVID-19 pandemic). We analyzed 3 pretest-posttest-posttest and 6 weekly survey measurements of affective empathy and burnout, and mean=85 (SD=31) aggregated daily resting heart rates per participant, using 2-level hierarchical linear modeling.
Results
The course found a preventive effect for leaders’ burnout escalation. As the control group awaited the course, their empathy decreased (coefficientTime=−1.27; P=.02) and their resting heart rates increased an average of 1.4 beats/min (coefficientTime=0.18; P<.001), reflecting the toll of the pandemic. Intervention group leaders reported no empathy decrements (coefficientTime=.33; P=.59) or escalated resting heart rate (coefficientTime=−0.05; P=.27) during the same period. Dose-response analysis revealed that both groups reduced their self-rated burnout over the 6 weeks of the course (coefficientTime=−0.28; P=.007), and those who attended more of the course showed less heart rate increase (coefficientTime∗Dosage=−0.05; P<.001). In addition, 12.73% of the within-person fluctuation in empathy was associated with burnout and resting heart rate.
Conclusion
A wellness leadership intervention helped prevent burnout escalation and empathy decrement in medical faculty leaders during the COVID-19 pandemic, showing potential to improve the supportiveness and psychological safety of the medical training environment.
{"title":"Impact of a Wellness Leadership Intervention on the Empathy, Burnout, and Resting Heart Rate of Medical Faculty","authors":"Debra A. Gilin PhD , Gregory G. Anderson MSc , Seyedehsan Etezad MSc , Dayna Lee-Baggley PhD , Angela M. Cooper PhD, RPsych , Roberta J. Preston EdD","doi":"10.1016/j.mayocpiqo.2023.09.005","DOIUrl":"https://doi.org/10.1016/j.mayocpiqo.2023.09.005","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the efficacy of a wellness leadership intervention for improving the empathy, burnout, and physiological stress of medical faculty leaders.</p></div><div><h3>Participants and Methods</h3><p>Participants were 49 medical faculty leaders (80% physicians, 20% basic scientists; 67% female). The 6-week course was evaluated with a 15-week longitudinal waitlist-control quasi-experiment from September 1, 2021, through December 20, 2021 (during the COVID-19 pandemic). We analyzed 3 pretest-posttest-posttest and 6 weekly survey measurements of affective empathy and burnout, and mean=85 (SD=31) aggregated daily resting heart rates per participant, using 2-level hierarchical linear modeling.</p></div><div><h3>Results</h3><p>The course found a preventive effect for leaders’ burnout escalation. As the control group awaited the course, their empathy decreased (coefficient<sub>Time</sub>=−1.27; <em>P</em>=.02) and their resting heart rates increased an average of 1.4 beats/min (coefficient<sub>Time</sub>=0.18; <em>P</em><.001), reflecting the toll of the pandemic. Intervention group leaders reported no empathy decrements (coefficient<sub>Time</sub>=.33; <em>P</em>=.59) or escalated resting heart rate (coefficient<sub>Time</sub>=−0.05; <em>P</em>=.27) during the same period. Dose-response analysis revealed that both groups reduced their self-rated burnout over the 6 weeks of the course (coefficient<sub>Time</sub>=−0.28; <em>P</em>=.007), and those who attended more of the course showed less heart rate increase (coefficient<sub>Time∗Dosage</sub>=−0.05; <em>P</em><.001). In addition, 12.73% of the within-person fluctuation in empathy was associated with burnout and resting heart rate.</p></div><div><h3>Conclusion</h3><p>A wellness leadership intervention helped prevent burnout escalation and empathy decrement in medical faculty leaders during the COVID-19 pandemic, showing potential to improve the supportiveness and psychological safety of the medical training environment.</p></div>","PeriodicalId":94132,"journal":{"name":"Mayo Clinic proceedings. Innovations, quality & outcomes","volume":"7 6","pages":"Pages 545-555"},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542454823000632/pdfft?md5=06b08332fb7a367a7844d8925992f219&pid=1-s2.0-S2542454823000632-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138413122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}